LLOYL.XC
Lloyds Banking Group plc
Cboe UKGBpEQUITY
Financial Services
DELAYED
Last price
111.10
▲ 1.27 (1.16%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
109.83
Day high
111.48
Day low
109.60
Volume
12.09M
Market cap
$65.08B
P/E (TTM)
1,388.75
52W range
77.40 – 117.80
Trailing performance
Returnvs SPY
1W
-3.48%
-2.1%
1M
-1.20%
-4.9%
3M
+9.62%
+6.5%
6M
+6.98%
-4.1%
YTD
+13.11%
+0.8%
1Y
+31.92%
+11.9%
3Y
+165.31%
+91.1%
5Y
+154.35%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LLOYL.XC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
43.56M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | Singh (Jas) |
BUY | 87 | $133 | Direct |
| Aug 10, 26 | Singh (Jas) |
— | 39 | — | Direct |
| Aug 10, 26 | Shelley (Stephen) |
BUY | 131 | $201 | Direct |
| Aug 10, 26 | Shelley (Stephen) |
— | 39 | — | Direct |
| Aug 10, 26 | Walton (Andrew) |
BUY | 26 | $39 | Direct |
| Aug 10, 26 | Walton (Andrew) |
— | 39 | — | Direct |
| Aug 10, 26 | Murphy (Amanda) |
BUY | 130 | $199 | Direct |
| Aug 10, 26 | Murphy (Amanda) |
— | 39 | — | Direct |
| Aug 10, 26 | Barua (Chirantan) |
BUY | 26 | $39 | Direct |
| Aug 10, 26 | Barua (Chirantan) |
— | 39 | — | Direct |
| Aug 10, 26 | Doherty (Sharon) |
BUY | 131 | $201 | Direct |
| Aug 10, 26 | Doherty (Sharon) |
— | 39 | — | Direct |
| Aug 10, 26 | Cheetham (Kate) |
BUY | 130 | $199 | Direct |
| Aug 10, 26 | Cheetham (Kate) |
— | 39 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BlackRock Advisors (UK) Limited |
— | 3.60B | Annual Return |
Budenberg (Robin F.) |
— | 2.50M | Annual Return |
Chalmers (William) |
— | 11.90M | Bought |
Harris Associates, L.P. |
— | 3.55B | Annual Return |
Lupton (Lord) |
— | 2.25M | Annual Return |
Norges Bank |
— | 1.94B | Annual Return |
Nunn (Charlie) |
— | 11.98M | Bought |
Shelley (Stephen) |
— | 4.94M | Bought |
Singh (Jas) |
— | 2.10M | Bought |
Winter John |
— | 1.94M | Bought |
Fundamentals
Market cap$65.08B
Enterprise value$62.53B
Revenue (TTM)$19.69B
Gross profit$19.69B
EBITDA—
Net income$4.76B
EPS (TTM)$0.08
Free cash flow—
Total cash$169.78B
Total debt$167.55B
Book value / share$0.71
Shares outstanding58.51B
Float54.64B
Short % of float—
Dividend yield3.61%
Beta (5Y)0.91
Valuation & profitability ratios
Trailing P/E1,388.75
Forward P/E—
PEG ratio0.73
Price / sales—
Price / book155.60
EV / revenue3.18
EV / EBITDA—
Gross margin0.00%
Operating margin44.96%
Profit margin26.43%
Return on equity11.34%
Return on assets0.56%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $20.03B | $18.60B | $19.20B | $16.05B | — | +7.7% |
| Operating revenue | $20.03B | $18.60B | $19.20B | $16.05B | — | +7.7% |
| Selling, general & admin | — | — | — | $435.00M | $371.00M | — |
| Total operating expense | $12.18B | $11.77B | $10.81B | $9.26B | — | +3.5% |
| Pre-tax income | $6.66B | $5.97B | $7.50B | $4.78B | — | +11.6% |
| Tax provision | $1.90B | $1.49B | $1.99B | $859.00M | — | +27.4% |
| Net income | $4.66B | $4.42B | $5.46B | $3.83B | — | +5.4% |
| Net income to common | $4.20B | $3.92B | $4.93B | $3.39B | — | +7.0% |
| Basic EPS | 0.07 | 0.06 | 0.08 | 0.07 | — | +11.1% |
| Diluted EPS | 0.07 | 0.06 | 0.08 | 0.07 | — | +11.3% |
| Basic shares | 59.79B | 62.41B | 64.95B | 68.85B | — | -4.2% |
| Diluted shares | 60.51B | 63.07B | 65.76B | 69.68B | — | -4.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $56.66B | $62.70B | $78.11B | $92.05B | -9.6% |
| Property, plant & equipment | $11.00B | $10.12B | $9.67B | $8.13B | +8.7% |
| Goodwill & intangibles | $8.59B | $8.19B | $8.31B | $7.62B | +4.9% |
| Total assets | $944.07B | $906.70B | $881.45B | $873.39B | +4.1% |
| Total debt | $95.14B | $88.52B | $93.67B | $91.83B | +7.5% |
| Total liabilities | $896.21B | $860.81B | $834.09B | $829.48B | +4.1% |
| Retained earnings | $6.29B | $5.91B | $6.79B | $6.55B | +6.4% |
| Shareholder equity | $47.67B | $45.72B | $47.16B | $43.67B | +4.3% |
| Net tangible assets | $39.08B | $37.53B | $38.86B | $36.05B | +4.1% |
| Shares issued | 58.89B | 60.62B | 63.57B | 67.29B | -2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $6.66B | $5.97B | $7.50B | $4.78B | +11.6% |
| Depreciation & amortisation | $3.48B | $3.43B | $2.90B | $2.40B | +1.5% |
| Change in working capital | -$5.29B | -$16.02B | -$4.88B | $18.22B | +67.0% |
| Operating cash flow | $5.70B | -$4.39B | $6.81B | $22.01B | +229.8% |
| Capital expenditure | -$6.32B | -$5.62B | -$5.46B | -$3.85B | -12.4% |
| Investing cash flow | -$10.19B | -$7.69B | -$9.82B | $510.00M | -32.5% |
| Share buybacks | -$1.71B | -$2.01B | -$1.99B | -$2.01B | +15.0% |
| Dividends paid | -$2.00B | -$1.83B | -$1.65B | -$1.48B | -9.4% |
| Financing cash flow | -$5.36B | -$5.93B | -$3.50B | -$6.61B | +9.7% |
| Free cash flow | -$622.00M | -$10.02B | $1.35B | $18.16B | +93.8% |
| End cash position | $60.59B | $70.82B | $88.84B | $95.83B | -14.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $5.73B | $5.18B | $5.78B | $4.56B | $5.00B | — | +10.6% |
| Operating revenue | $5.73B | $5.18B | $5.78B | $4.56B | $5.00B | — | +10.6% |
| Total operating expense | $3.00B | $2.85B | $3.24B | $3.49B | $2.58B | — | +5.5% |
| Pre-tax income | $2.27B | $2.02B | $1.98B | $1.17B | $1.99B | — | +12.0% |
| Tax provision | $700.00M | $470.00M | $548.00M | $396.00M | $577.00M | — | +48.9% |
| Net income | $1.53B | $1.53B | $1.40B | $738.00M | $1.39B | — | +0.2% |
| Net income to common | $1.42B | $1.41B | $1.30B | $618.00M | $1.27B | — | +0.7% |
| Basic EPS | — | 0.02 | — | — | — | 0.02 | — |
| Diluted EPS | — | 0.02 | — | — | — | 0.02 | — |
| Basic shares | — | 58.80B | — | — | — | 60.59B | — |
| Diluted shares | — | 58.80B | — | — | — | 60.59B | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $61.53B | $62.13B | $56.66B | $61.85B | $64.22B | — | -1.0% |
| Property, plant & equipment | — | — | $11.00B | — | — | $10.12B | — |
| Goodwill & intangibles | $8.73B | — | $8.59B | — | $8.04B | $8.19B | — |
| Total assets | $994.16B | $968.13B | $944.07B | $937.46B | $919.28B | — | +2.7% |
| Total debt | $106.50B | $100.75B | $95.14B | $88.31B | $85.44B | — | +5.7% |
| Total liabilities | $946.92B | $919.89B | $896.21B | $891.83B | $872.41B | — | +2.9% |
| Retained earnings | $6.24B | — | $6.29B | — | $5.62B | $5.91B | — |
| Shareholder equity | $47.01B | $48.03B | $47.67B | $45.48B | $46.72B | — | -2.1% |
| Net tangible assets | $38.28B | $48.03B | $39.08B | $45.48B | $38.67B | — | -20.3% |
| Shares issued | 58.27B | 58.63B | 58.89B | 59.28B | 60.03B | — | -0.6% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $5.60B | +11.9% |
| Next quarter | — | — | $5.70B | +11.2% |
| Current year | — | — | $21.82B | +10.5% |
| Next year | — | — | $23.68B | +8.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.07%
Held by institutions51.32%
Institutions holding557
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
113.29
-1.94% from price
SMA 20
114.25
-2.75% from price
SMA 50
112.07
-0.86% from price
SMA 100
105.55
+5.26% from price
SMA 200
101.82
+9.11% from price
EMA 12
112.97
-1.66% from price
EMA 26
113.05
-1.73% from price
EMA 50
111.13
-0.02% from price
RSI (14)
43.7
Neutral
MACD (12,26,9)
-0.08
Hist -0.81
ATR (14)
1.71
1.54% of price
Realised vol 30D
20.0%
Annualised
Bollinger upper
118.24
20, 2σ
Bollinger lower
110.25
20, 2σ
50 / 200 cross
Golden
112.07 vs 101.82
Trend bias
Above 200
+9.11%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.40
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
20.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-19.4%
Peak to trough
Max drawdown 5Y
-28.8%
Peak to trough
ATR 14
1.71
1.54% of price
Beta (reported)
0.91
5Y monthly, from filing
Dividends & splits
Forward rate$0.04 / yr
Forward yield3.61%
5-year avg yield4.33%
Payout ratio45.63%
Ex-dividend dateAug 6, 2026
Next pay date—
Last split41:40
Split dateMay 11, 2009
Headlines
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
ACCESS Newswire · 5m ago
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · 5m ago
Dollar trading near multi-month lows, restrained by debt nerves
Reuters · 6m ago
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 15m ago
TME Pharma provides update on its activities
GlobeNewswire · 15m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 20m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 20m ago
Board Update
GlobeNewswire · 20m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.